Penumbra, Inc. (PEN)
323.10
+1.42
(+0.44%)
USD |
NYSE |
Aug 31, 16:00
323.27
+0.17
(+0.05%)
Pre-Market: 20:00
Penumbra Cash from Operations (Annual) : 238.66M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 238.66M |
| December 31, 2024 | 168.48M |
| December 31, 2023 | 97.33M |
| December 31, 2022 | -55.66M |
| December 31, 2021 | 9.502M |
| December 31, 2020 | -33.24M |
| December 31, 2019 | 26.65M |
| Date | Value |
|---|---|
| December 31, 2018 | 28.81M |
| December 31, 2017 | 12.69M |
| December 31, 2016 | -12.81M |
| December 31, 2015 | -22.28M |
| December 31, 2014 | -6.389M |
| December 31, 2013 | -3.396M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Boston Scientific Corp. | 4.534B |
| Globus Medical, Inc. | 753.45M |
| Teleflex, Inc. | 340.68M |
| Abbott Laboratories | 9.566B |
| AngioDynamics, Inc. | 3.089M |